| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |